Sign in

CIK 0001034842 · Accelerated filer

RIGEL PHARMACEUTICALS INC

Sign in to watch
Ticker
RIGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
943248524
Phone
650-624-1100
Business address
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
Former names
RIGEL PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-28 RODRIGUEZ RAUL R CEO, President Grant or award · Employee Stock Option (right to buy) +300,000 300,000
2024-02-28 RODRIGUEZ RAUL R CEO, President Grant or award · Employee Stock Option (right to buy) +300,000 300,000
2024-02-28 Furey Raymond J. EVP, GC, CCO & Corp Sec Grant or award · Employee Stock Option (right to buy) +93,750 93,750
2024-02-28 Furey Raymond J. EVP, GC, CCO & Corp Sec Grant or award · Employee Stock Option (right to buy) +78,500 78,500
2024-02-05 Santos David A EVP, Chief Commercial Officer Sale −8,918 $1.14 $10K 349,093
2024-02-05 Schorno Dean L EVP & Chief Financial Officer Sale −7,027 $1.14 $8K 402,891
2024-02-05 RODRIGUEZ RAUL R CEO, President Sale −30,545 $1.14 $35K 2,036,629
2024-02-02 Santos David A EVP, Chief Commercial Officer Sale −5,601 $1.13 $6K 358,011
2024-02-02 Schorno Dean L EVP & Chief Financial Officer Sale −5,601 $1.13 $6K 409,918
2024-02-02 RODRIGUEZ RAUL R CEO, President Sale −22,349 $1.13 $25K 2,067,174
2024-01-23 Furey Raymond J. EVP, GC, CCO & Corp Sec Grant or award +209,000 214,000
2024-01-23 Furey Raymond J. EVP, GC, CCO & Corp Sec Grant or award · Employee Stock Option (Right to Buy) +157,000 157,000
2024-01-23 RODRIGUEZ RAUL R CEO, President Grant or award +400,000 2,089,523
2024-01-23 RODRIGUEZ RAUL R CEO, President Grant or award · Employee Stock Option (Right to Buy) +600,000 600,000
2024-01-23 Santos David A EVP, Chief Commercial Officer Grant or award +209,000 363,612
2024-01-23 Santos David A EVP, Chief Commercial Officer Grant or award · Employee Stock Option (Right to Buy) +157,000 157,000
2024-01-23 Schorno Dean L EVP & Chief Financial Officer Grant or award +209,000 415,519
2024-01-23 Schorno Dean L EVP & Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +157,000 157,000
2023-05-26 Wasman Jane Director Grant or award +25,000 75,000
2023-05-26 Wasman Jane Director Grant or award · Stock Option (Right to Buy) +30,000 30,000

Page 8 of 9 · 176 trades